Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. Anthrax Vaccine: Safety and Efficacy Issues. T-NSIAD-00-48. Washington, DC, 1999. https://www.govinfo.gov/app/details/GAOREPORTS-T-NSIAD-00-48.
National Security and International Affairs Division, Government Accountability Office. (1999, October 12). GAO/T-NSIAD-00-48 - Anthrax Vaccine: Safety and Efficacy Issues. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/GAOREPORTS-T-NSIAD-00-48
National Security and International Affairs Division, Government Accountability Office. GAO/T-NSIAD-00-48 - Anthrax Vaccine: Safety and Efficacy Issues. U.S. Government Printing Office, (12 Oct 1999), https://www.govinfo.gov/app/details/GAOREPORTS-T-NSIAD-00-48
National Security and International Affairs Division, Government Accountability Office, Anthrax Vaccine: Safety and Efficacy Issues, GovInfo, (October 12, 1999), https://www.govinfo.gov/app/details/GAOREPORTS-T-NSIAD-00-48